Below you will find the latest news from AbSorber. For further information please contact Anders Karlsson, CEO of AbSorber.
Clinical use of XM-ONE® was highlighted at a symposium at the annual American Society of Histocompatibility and Immunogetetics (ASHI) meeting in New Orleans
New study confirms that XM-ONE® identifies kidney transplant recipients at increased risk for acute rejection.
AbSorber to host a Scientific Symposium at the American Transplant Congress in Philadelphia, PA
AbSorber and Olerup SSP has signed an exclusive distribution agreement for the Brazilian market, the world's second largest transplantation market after the US. Partner in Brazil is Genese Produtos Diagnosticos Ltda in Sao Paulo.
AbSorber has submitted a 510K to the FDA (U.S. Food and Drug Administration) for a new version of the Company’s transplantation crossmatch, XM-ONE®. This new version has the potential to replace current flow Cytometry based crossmatch tests.